Company Legal Name
Latest Valuation
Founded Year
Headquarter
Remedio Technologies operates a cybersecurity platform that provides automated device posture management solutions for enterprise environments. Founded in 2019 and headquartered in Tel Aviv, the company addresses critical security gaps by continuously monitoring and securing endpoint devices across corporate networks. Remedio's platform automates the traditionally manual process of device security assessment, enabling organizations to maintain comprehensive visibility and control over their device ecosystems. The company focuses on streamlining cybersecurity operations while reducing the complexity and resource burden typically associated with enterprise device management, positioning itself within the growing endpoint security and device management market segment.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





